Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Patient
83%
Infection
78%
Analysis
46%
Therapeutic Procedure
41%
COVID-19
39%
Disease Severity
32%
Hospital
32%
Intensive Care Unit
32%
Pathogen
30%
Intensive Care
28%
Association
18%
Disease
18%
Public Health
18%
Man
16%
Woman
16%
Cohort Analysis
16%
Secondary Infection
16%
Aortic Graft
16%
Drug
16%
Prosthetics
16%
Antiinfective Agent
16%
Respiratory Tract Infection
16%
Lower Respiratory Tract Infection
16%
Laboratory
15%
Mortality
13%
Antimicrobial Therapy
12%
Gene
12%
Diagnosis
11%
Logistic Regression Analysis
11%
RNA
10%
Organism
9%
Virus Genome
9%
Electronic Health Record
9%
Health
8%
Culture
8%
Tropheryma whipplei
8%
Teglicar
8%
Legionella pneumophila
8%
Water
8%
Mycobacterium Tuberculosis
8%
Cytomegalovirus
8%
Virulence
8%
Species Differentiation
8%
Staphylococcus Aureus
8%
Hypoxia
7%
Multivariate Analysis
6%
Clinical Method
6%
Age
5%
Infection Prevention
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Neutralization
18%
COVID-19
18%
Resistome
16%
Breakthrough Infection
16%
Omicron Coronavirus Variant
16%
Lineages
16%
Influenzavirus A
16%
Variovorax
16%
Superantigen
16%
Receptor Binding
8%
Neutralizing Antibody
8%
Antimicrobial Resistance
6%
